Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol

Neuropharmacology

Volumn 54, Issue 1, 2008, Pages 31-35

  Borgkvist, Anders ^a   Marcellino, Daniel ^a   Fuxe, Kjell ^a   Greengard, Paul ^b   Fisone, Gilberto ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adenosine A2A receptor; Basal ganglia; Dopamine D1 receptor; KW6002; SCH23390; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE A2A RECEPTOR; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DRONABINOL; ISTRADEFYLLINE; PHOSPHOPROTEIN DARPP 32; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; CORPUS STRIATUM; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MICE; MICE, INBRED C57BL; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PSYCHOTROPIC DRUGS; PURINES; TETRAHYDROCANNABINOL; THREONINE; TIME FACTORS;

EID: 37349015526     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.06.025     Document Type: Article

References (32)

1. Andersson M., Usiello A., Borgkvist A., Pozzi L., Dominguez C., Fienberg A.A., Svenningsson P., Fredholm B.B., Borrelli E., Greengard P., and Fisone G. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J. Neurosci. 25 (2005) 8432-8438
2. Borgkvist, A., Usiello, A., Greengard, P., Fisone, G., 2007. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology, doi: 10.1038/sj.npp.1301374.
3. Carriba P., Ortiz O., Patkar K., Justinova Z., Stroik J., Themann A., Muller C., Woods A.S., Hope B.T., Ciruela F., Casado V., Canela E.I., Lluis C., Goldberg S.R., Moratalla R., Franco R., and Ferre S. Striatal adenosine A(2A) and cannabinoid CB(1) receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology (2007) 10.1038/sj.npp.1301375
4. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., Corbett R., Haile C.N., Cooper D.C., Onn S.P., Grace A.A., Ouimet C.C., White F.J., Hyman S.E., Surmeier D.J., Girault J., Nestler E.J., and Greengard P. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281 (1998) 838-842
5. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., and Reppert S.M. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptor in rat striatum. Mol. Brain Res. 14 (1992) 186-195
6. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
7. French E.D., Dillon K., and Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8 (1997) 649-652
8. Gerdeman G., and Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85 (2001) 468-471
9. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann. Rev. Neurosci. 15 (1992) 285-320
10. Halpain S., Girault J.-A., and Greengard P. NMDA receptor activation induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343 (1990) 369-372
11. Hemmings H.C.J., and Greengard P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J. Neurosci. 6 (1986) 1469-1481
12. Hemmings Jr. H.C., Greengard P., Tung H.Y., and Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310 (1984) 503-505
13. Herkenham M., Lynn A.B., de Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547 (1991) 267-274
14. Hohmann A.G., and Herkenham M. Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 37 (2000) 71-80
15. 1 receptor knockout mice. Science 283 (1999) 401-404
16. Lindskog M., Svenningsson P., Pozzi L., Kim Y., Fienberg A.A., Bibb J.A., Fredholm B.B., Nairn A.C., Greengard P., and Fisone G. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418 (2002) 774-778
17. Matyas F., Yanovsky Y., Mackie K., Kelsch W., Misgeld U., and Freund T.F. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137 (2006) 337-361
18. Melis M., Gessa G.L., and Diana M. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. Prog. Neuropsychopharmacol. Biol. Psychiatry. 24 (2000) 993-1006
19. Narushima M., Hashimoto K., and Kano M. Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum. Neurosci. Res. 54 (2006) 159-164
20. Ouimet C.C., Langley-Gullion K.C., and Greengard P. Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res. 808 (1998) 8-12
21. Sanudo-Pena M.C., Tsou K., and Walker J.M. Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci. 65 (1999) 703-713
22. Schiffmann S.N., Jacobs O., and Vanderhaegen J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57 (1991) 1062-1067
23. Snyder G.L., Girault J.A., Chen J.Y., Czernik A.J., Kebabian J.W., Nathanson J.A., and Greengard P. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J. Neurosci. 12 (1992) 3071-3083
24. Snyder G.L., Fisone G., and Greengard P. Phosphorylation of DARPP-32 is regulated by GABA in rat striatum and substantia nigra. J. Neurochem. 63 (1994) 1766-1771
25. 1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience 84 (1998) 223-228
26. Svenningsson P., Lindskog M., Ledent C., Parmentier M., Greengard P., Fredholm B.B., and Fisone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1856-1860
27. Szabo B., Dörner L., Pfreundtner C., Nörenberg W., and Starke K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85 (1998) 395-403
28. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 4350-4354
29. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., and Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27 (2007) 3663-3676
30. van der Stelt M., and Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol. 480 (2003) 133-150
31. Walaas S.I., and Greengard P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in rat brain. J. Neurosci. 4 (1984) 84-98
32. Zachariou V., Sgambato-Faure V., Sasaki T., Svenningsson P., Berton O., Fienberg A.A., Nairn A.C., Greengard P., and Nestler E.J. Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology 31 (2006) 555-562